跳至主要内容
临床试验/CTRI/2018/02/012158
CTRI/2018/02/012158尚未招募未知

A 12â??month prospective observational study assessing the real-world clinical effectiveness, safety and health-economic benefits of Toujeo® initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus - ATOS

Sanofi India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Signed patient informed consent;
  • 2. Type 2 diabetes mellitus;
  • 3. Treated with at least 1 OAD for at least 6 months;
  • 4. Legal age of adulthood, but at least >=18 years;
  • 5. HbA1c >7.0 % and <=11% within 3 months of study baseline;
  • 6. Physiciansâ?? decision in accordance with the current local guidelines to add basal insulin glargine U300 to an existing OAD regimen

排除标准

  • 1. Diabetes mellitus other than type 2;
  • 2. Existing or previous treatment with insulin or other injectable antidiabetic drugs. The
  • following is allowed:
  • - Previous short-term insulin treatment due to an intercurrent medical condition,
  • with treatment duration not exceeding 10 concurrent days in the past year;
  • - Previous insulin treatment of gestational diabetes, if the patient has discontinued
  • insulin treatment more than a year ago.
  • 3. Contraindication to insulin glargine U300 according to local product labelling;
  • 4. Pregnancy, breastfeeding or pregnancy planned during the course of the study;
  • 5. Drug or alcohol abuse within the past year;
  • 6. Concomitant disease with life expectancy of less than 1 year;
  • 7. Concomitant participation in a clinical trial

研究者

相似试验

撤回
不适用
A 12-month Longitudinal, Prospective, Observational, Natural History Study of Patients with Sanfilippo Syndrome Type A (MPS IIIA)MPS IIIASanfilippo syndrome Type A1002742410057167
NL-OMON32977Shire Human Genetic Therapies5
撤回
4 期
The brolucizumab anti-vascular endothelial growth factor (anti-VEGF) treatment of Age-Related Macular Degeneration (AMD) Switch Study,wet age related macular degenerationEye - Diseases / disorders of the eye
ACTRN12621000624886Clinical Professor Nitin Verma50
尚未招募
不适用
A 12-month, non-interventional, observational multinational study to evaluate effectiveness, tolerability, and quality of life of brivaracetam adjunctive therapy in earlier treatment lines in adult patients with history of partial-onset seizures in daily clinical practice.
DRKS00025524Parexel International (IRL) Limited (Clinical Research Organisation)600
招募中
不适用
A change of End tidal Carbon dioxide(EtCO2) during Endoscopic Retrograde Cholangiopancreatography(ERCP) with Carbon dioxide insufflation under general anesthesia with controlled ventilatioEndoscopic Retrograde Cholangiopancreatography (ERCP) with Carbon dioxide (CO2) insufflation in patient ASA physical status 1-3 under general anesthesia with controlled ventilationEndoscopic Retrograde Cholangiopancreatography (ERCP) with Carbon dioxide (CO2) insufflationEnd tidal Carbon dioxide (EtCO2)
TCTR20210824003Department of Anesthesiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University125
招募中
4 期
A 12 month, open label, multi-center study to evaluate the efficacy and safety of intravitreal injections of ranibizumab 0.5 mg on Cystoid, Spongy & Mixed OCT patterns secondary to Diabetic Macular Edema (DME)
CTRI/2014/02/004379Dr V Narendran300